Advanced Transformation Facility Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 06-11-2024
- Paid Up Capital ₹ 0.10 M
as on 06-11-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit 90.16%
(FY 2022)
- Ebitda 97.97%
(FY 2022)
- Net Worth -15.83%
(FY 2022)
- Total Assets -43.61%
(FY 2022)
About Advanced Transformation Facility
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Chandra Singavarapu and Arvind Anegondi serve as directors at the Company.
- CIN/LLPIN
U24230TG2020PTC143663
- Company No.
143663
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Advanced Transformation Facility?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandra Singavarapu  | Director | 08-Sep-2020 | Current |
| Arvind Anegondi | Director | 08-Sep-2020 | Current |
Financial Performance of Advanced Transformation Facility.
Advanced Transformation Facility Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 90.16% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Advanced Transformation Facility?
Unlock access to Advanced Transformation Facility's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Bhagiradha Chemicals And Industries Ltd.Active 31 years 6 monthsChandra Singavarapu and Arvind Anegondi are mutual person
Bheema Fine Chemicals Private LimitedActive 4 years 6 monthsChandra Singavarapu and Arvind Anegondi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Advanced Transformation Facility?
Advanced Transformation Facility has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advanced Transformation Facility, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advanced Transformation Facility's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
